Merck Cash on Hand 2010-2024 | MRK

Merck cash on hand for the quarter ending June 30, 2024 was $11.354B, a 78.02% increase year-over-year.

  • Merck cash on hand for 2023 was $7.093B, a 46.23% decline from 2022.
  • Merck cash on hand for 2022 was $13.192B, a 62.94% increase from 2021.
  • Merck cash on hand for 2021 was $8.096B, a 0.57% increase from 2020.

Merck Cash on Hand 2010-2024 | MRK

  • Merck cash on hand for 2023 was $7.093B, a 46.23% decline from 2022.
  • Merck cash on hand for 2022 was $13.192B, a 62.94% increase from 2021.
  • Merck cash on hand for 2021 was $8.096B, a 0.57% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$861.3B
Novo Nordisk (NVO)$592.4B
Johnson & Johnson (JNJ)$402.2B
AbbVie (ABBV)$341.7B
AstraZeneca (AZN)$243.5B
Novartis AG (NVS)$236.5B
Pfizer (PFE)$169B
Sanofi (SNY)$144.1B
Innoviva (INVA)$1.2B